iNtRON Biotechnology Inc (048530) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, iNtRON Biotechnology Inc (048530) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-993.53 Million ≈ $-673.30K USD) by net assets (₩73.98 Billion ≈ $50.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can iNtRON Biotechnology Inc fund operations to measure how many days the company can operate on defensive assets alone.

iNtRON Biotechnology Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how iNtRON Biotechnology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

iNtRON Biotechnology Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iNtRON Biotechnology Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Farmsco KO:036580	0.097x
Borgestad A OL:BOR	0.121x
CBAK ENERGY TECH. NEW F:B6JA	0.272x
Osteonic Co. Ltd KQ:226400	0.017x
CALIX Ltd AU:CXL	-0.134x
Norcod As OL:NCOD	-0.333x
Air T Inc NASDAQ:AIRT	-3.137x
Yenher Holdings Bhd KLSE:5300	0.028x

Annual Cash Flow Conversion Efficiency for iNtRON Biotechnology Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of iNtRON Biotechnology Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 048530 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩83.77 Billion ≈ $56.77 Million	₩-138.47 Million ≈ $-93.84K	-0.002x	-105.13%
2023-12-31	₩96.73 Billion ≈ $65.56 Million	₩3.12 Billion ≈ $2.11 Million	0.032x	-42.74%
2022-12-31	₩106.18 Billion ≈ $71.96 Million	₩5.98 Billion ≈ $4.05 Million	0.056x	-65.37%
2021-12-31	₩101.35 Billion ≈ $68.68 Million	₩16.47 Billion ≈ $11.16 Million	0.163x	+94.60%
2020-12-31	₩85.38 Billion ≈ $57.86 Million	₩7.13 Billion ≈ $4.83 Million	0.084x	+767.82%
2019-12-31	₩64.96 Billion ≈ $44.02 Million	₩-812.48 Million ≈ $-550.61K	-0.013x	-111.64%
2018-12-31	₩39.09 Billion ≈ $26.49 Million	₩4.20 Billion ≈ $2.85 Million	0.107x	+159.44%
2017-12-31	₩30.24 Billion ≈ $20.50 Million	₩-5.47 Billion ≈ $-3.71 Million	-0.181x	-91.32%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-4.64 Billion ≈ $-3.15 Million	-0.094x	-291.53%
2015-12-31	₩34.44 Billion ≈ $23.34 Million	₩1.70 Billion ≈ $1.15 Million	0.049x	+277.79%
2012-12-31	₩11.93 Billion ≈ $8.08 Million	₩-331.01 Million ≈ $-224.32K	-0.028x	--

About iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$59.56 Million

₩87.89 Billion KRW

Market Cap Rank

#21279 Global

#1226 in Korea

Share Price

₩2780.00

Change (1 day)

-1.59%

52-Week Range

₩2555.00 - ₩6650.00

All Time High

₩46250.00